- Home
- OPBK vs OSUR Comparison
OPBK vs OSUR Comparison
Compare OPBK & OSUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OPBK
- OSUR
- Stock Information
- Founded
- OPBK 2005
- OSUR 2000
- Country
- OPBK United States
- OSUR United States
- Employees
- OPBK N/A
- OSUR N/A
- Industry
- OPBK Major Banks
- OSUR Medical/Dental Instruments
- Sector
- OPBK Finance
- OSUR Health Care
- Exchange
- OPBK Nasdaq
- OSUR Nasdaq
- Market Cap
- OPBK 257.1M
- OSUR 289.4M
- IPO Year
- OPBK 2018
- OSUR 1986
- Fundamental
- Price
- OPBK $16.21
- OSUR $3.79
- Analyst Decision
- OPBK Hold
- OSUR Hold
- Analyst Count
- OPBK 1
- OSUR 2
- Target Price
- OPBK $13.00
- OSUR $5.50
- AVG Volume (30 Days)
- OPBK 25.5K
- OSUR 882.2K
- Earning Date
- OPBK 01-23-2025
- OSUR 11-06-2024
- Dividend Yield
- OPBK 2.80%
- OSUR N/A
- EPS Growth
- OPBK N/A
- OSUR N/A
- EPS
- OPBK 1.40
- OSUR 0.15
- Revenue
- OPBK $78,759,000.00
- OSUR $224,263,000.00
- Revenue This Year
- OPBK N/A
- OSUR N/A
- Revenue Next Year
- OPBK $12.64
- OSUR N/A
- P/E Ratio
- OPBK $11.28
- OSUR $25.09
- Revenue Growth
- OPBK N/A
- OSUR N/A
- 52 Week Low
- OPBK $8.91
- OSUR $3.72
- 52 Week High
- OPBK $18.57
- OSUR $8.45
- Technical
- Relative Strength Index (RSI)
- OPBK 52.12
- OSUR 43.14
- Support Level
- OPBK $16.75
- OSUR $3.78
- Resistance Level
- OPBK $17.36
- OSUR $4.14
- Average True Range (ATR)
- OPBK 0.56
- OSUR 0.18
- MACD
- OPBK -0.20
- OSUR 0.00
- Stochastic Oscillator
- OPBK 14.80
- OSUR 9.30
About OPBK OP Bancorp
OP Bancorp is engaged in the general commercial banking business in Los Angeles, Orange, and Santa Clara Counties, California, Carrollton, Texas, and Las Vegas, Nevada. The Bank is focused on serving the banking needs of small- and medium-sized businesses, professionals, and residents with a particular emphasis on Korean and other ethnic minority communities. It operates with eleven full branches.
About OSUR OraSure Technologies Inc.
OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.